Prostate Cancer Screening-Global Market Status and Trend Report 2016-2026

Table of Contents

Chapter 1 Overview of Prostate Cancer Screening

• 1.1 Definition of Prostate Cancer Screening in This Report
• 1.2 Commercial Types of Prostate Cancer Screening
  • 1.2.1 Physical Exam
  • 1.2.2 Laboratory Tests
  • 1.2.3 Imaging Tests
  • 1.2.4 Gleason Score
  • 1.2.5 TNM Score
  • 1.2.6 Genetic Tests
  • 1.2.7 Digital Rectal Exam
  • 1.2.8 Biopsy
• 1.3 Downstream Application of Prostate Cancer Screening
  • 1.3.1 Hospitals
  • 1.3.2 Clinics
  • 1.3.3 Research Labs
  • 1.3.4 Cancer Institutes
  • 1.3.5 Diagnostic Centers
  • 1.3.6 Others
• 1.4 Development History of Prostate Cancer Screening
• 1.5 Market Status and Trend of Prostate Cancer Screening 2016-2026
  • 1.5.1 Global Prostate Cancer Screening Market Status and Trend 2016-2026
  • 1.5.2 Regional Prostate Cancer Screening Market Status and Trend 2016-2026

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Prostate Cancer Screening 2016-2021
• 2.2 Production Market of Prostate Cancer Screening by Regions
  • 2.2.1 Production Volume of Prostate Cancer Screening by Regions
  • 2.2.2 Production Value of Prostate Cancer Screening by Regions
• 2.3 Demand Market of Prostate Cancer Screening by Regions
• 2.4 Production and Demand Status of Prostate Cancer Screening by Regions
  • 2.4.1 Production and Demand Status of Prostate Cancer Screening by Regions 2016-2021
  • 2.4.2 Import and Export Status of Prostate Cancer Screening by Regions 2016-2021

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Prostate Cancer Screening by Types
• 3.2 Production Value of Prostate Cancer Screening by Types
• 3.3 Market Forecast of Prostate Cancer Screening by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Prostate Cancer Screening by Downstream Industry
• 4.2 Market Forecast of Prostate Cancer Screening by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Prostate Cancer Screening

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Prostate Cancer Screening Downstream Industry Situation and Trend Overview

Chapter 6 Prostate Cancer Screening Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Prostate Cancer Screening by Major Manufacturers
• 6.2 Production Value of Prostate Cancer Screening by Major Manufacturers
• 6.3 Basic Information of Prostate Cancer Screening by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Prostate Cancer Screening Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Prostate Cancer Screening Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Prostate Cancer Screening Major Manufacturers Introduction and Market Data

• 7.1 Abbott Laboratories
  • 7.1.1 Company profile
  • 7.1.2 Representative Prostate Cancer Screening Product
  • 7.1.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Abbott Laboratories
• 7.2 Almac
  • 7.2.1 Company profile
  • 7.2.2 Representative Prostate Cancer Screening Product
  • 7.2.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Almac
• 7.3 Bayer
  • 7.3.1 Company profile
  • 7.3.2 Representative Prostate Cancer Screening Product
  • 7.3.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Bayer
• 7.4 Beckman Coulter
  • 7.4.1 Company profile
  • 7.4.2 Representative Prostate Cancer Screening Product
  • 7.4.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Beckman Coulter
• 7.5 BioméRieux
  • 7.5.1 Company profile
  • 7.5.2 Representative Prostate Cancer Screening Product
  • 7.5.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of BioméRieux
• 7.6 Genomic Health
  • 7.6.1 Company profile
  • 7.6.2 Representative Prostate Cancer Screening Product
  • 7.6.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Genomic Health
• 7.7 Mayo Clinic
  • 7.7.1 Company profile
  • 7.7.2 Representative Prostate Cancer Screening Product
  • 7.7.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Mayo Clinic
• 7.8 Mdxhealth
  • 7.8.1 Company profile
  • 7.8.2 Representative Prostate Cancer Screening Product
  • 7.8.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Mdxhealth
• 7.9 Roche Diagnostics
  • 7.9.1 Company profile
  • 7.9.2 Representative Prostate Cancer Screening Product
  • 7.9.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Roche Diagnostics
• 7.10 Rosetta Genomics
  • 7.10.1 Company profile
  • 7.10.2 Representative Prostate Cancer Screening Product
  • 7.10.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Rosetta Genomics
• 7.11 Thermo Fisher Scientific
  • 7.11.1 Company profile
  • 7.11.2 Representative Prostate Cancer Screening Product
  • 7.11.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
• 7.12 Hologic
  • 7.12.1 Company profile
  • 7.12.2 Representative Prostate Cancer Screening Product
  • 7.12.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Hologic
• 7.13 Myriad Genetics
  • 7.13.1 Company profile
  • 7.13.2 Representative Prostate Cancer Screening Product
  • 7.13.3 Prostate Cancer Screening Sales, Revenue, Price and Gross Margin of Myriad Genetics

Chapter 8 Upstream and Downstream Market Analysis of Prostate Cancer Screening

• 8.1 Industry Chain of Prostate Cancer Screening
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Prostate Cancer Screening

• 9.1 Cost Structure Analysis of Prostate Cancer Screening
• 9.2 Raw Materials Cost Analysis of Prostate Cancer Screening
• 9.3 Labor Cost Analysis of Prostate Cancer Screening
• 9.4 Manufacturing Expenses Analysis of Prostate Cancer Screening

Chapter 10 Marketing Status Analysis of Prostate Cancer Screening

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources